Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY

v2.4.0.8
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (USD $)
In Thousands
Total
Common Shares [Member]
Paid-in Capital in Excess of par Value [Member]
Accumulated Other Comprehensive Loss [Member]
Retained Earnings [Member]
Beginning Balance at Dec. 31, 2009 $ 351,218 $ 120 $ 222,882 $ (23,396) $ 151,612
Issuance of 3.3 million , 3.7 million and 2.1 million common shares from exercise of stock options, SARs, restricted stock units, employee stock purchase plan, in 2010, 2011 and 2012 respectively and 0.4 million, 0.4 million from exercise of warrants, in 2011 and 2012 respectively 15,309 4 15,305    
Excess tax benefit from exercise of stock options, SARs and restricted stock grants 9,254   9,254    
Additional capital from share based compensation 22,969   22,969    
Repurchases of 6.0 million, 6.0 million and 11.5 million common shares in 2010, 2011 and 2012 respectively (160,008) (6) (21,088)   (138,914)
Dividends and dividend equivalents ($0.45 per share,$0.73 per share, $1.20 per share) in 2010, 2011, and 2012 respectively (53,740)   580   (54,320)
Net income 292,883       292,883
Foreign currency translation adjustment, net of income taxes of ($3,090) and $283 in 2011 and 2012 respectively 583     583  
Unrealized gain (loss) on derivatives, net of income taxes of ($1,222), $1,455 and ($ 1,161) in 2010, 2011 and 2012 respectively (4,472)     (4,472)  
Ending Balance at Dec. 31, 2010 473,996 118 249,902 (27,285) 251,261
Issuance of 3.3 million , 3.7 million and 2.1 million common shares from exercise of stock options, SARs, restricted stock units, employee stock purchase plan, in 2010, 2011 and 2012 respectively and 0.4 million, 0.4 million from exercise of warrants, in 2011 and 2012 respectively 26,467 4 26,463    
Excess tax benefit from exercise of stock options, SARs and restricted stock grants 26,241   26,241    
Additional capital from share based compensation 24,133   24,133    
Repurchases of 6.0 million, 6.0 million and 11.5 million common shares in 2010, 2011 and 2012 respectively (321,639) (6) (35,427)   (286,206)
Dividends and dividend equivalents ($0.45 per share,$0.73 per share, $1.20 per share) in 2010, 2011, and 2012 respectively (85,489)   638   (86,127)
Net income 414,959       414,959
Foreign currency translation adjustment, net of income taxes of ($3,090) and $283 in 2011 and 2012 respectively (16,757)     (16,757)  
Unrealized gain (loss) on derivatives, net of income taxes of ($1,222), $1,455 and ($ 1,161) in 2010, 2011 and 2012 respectively 6,233     6,233  
Ending Balance at Dec. 31, 2011 548,144 116 291,950 (37,809) 293,887
Issuance of 3.3 million , 3.7 million and 2.1 million common shares from exercise of stock options, SARs, restricted stock units, employee stock purchase plan, in 2010, 2011 and 2012 respectively and 0.4 million, 0.4 million from exercise of warrants, in 2011 and 2012 respectively 11,264 3 11,261    
Excess tax benefit from exercise of stock options, SARs and restricted stock grants 29,684   29,684    
Additional capital from share based compensation 28,133   28,133    
Repurchases of 6.0 million, 6.0 million and 11.5 million common shares in 2010, 2011 and 2012 respectively (556,727) (12) (57,655)   (499,060)
Dividends and dividend equivalents ($0.45 per share,$0.73 per share, $1.20 per share) in 2010, 2011, and 2012 respectively (135,091)   602   (135,693)
Net income 463,962       463,962
Foreign currency translation adjustment, net of income taxes of ($3,090) and $283 in 2011 and 2012 respectively 9,821     9,821  
Unrealized gain (loss) on derivatives, net of income taxes of ($1,222), $1,455 and ($ 1,161) in 2010, 2011 and 2012 respectively (3,707)     (3,707)  
Ending Balance at Dec. 31, 2012 $ 395,483 $ 107 $ 303,975 $ (31,695) $ 123,096